Imperial College London

ProfessorMikeLaffan

Faculty of MedicineDepartment of Immunology and Inflammation

Visiting Professor
 
 
 
//

Contact

 

+44 (0)20 3313 2178m.laffan

 
 
//

Assistant

 

Mrs Lisa Pape +44 (0)20 3313 1320

 
//

Location

 

5S5bHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Connell:2021:10.1182/bloodadvances.2020003264,
author = {Connell, NT and Flood, VH and Brignardello-Petersen, R and Abdul-Kadir, R and Arapshian, A and Couper, S and Grow, JM and Kouides, P and Laffan, M and Lavin, M and Leebeek, FWG and O'Brien, SH and Ozelo, MC and Tosetto, A and Weyand, AC and James, PD and Kalot, MA and Husainat, N and Mustafa, RA},
doi = {10.1182/bloodadvances.2020003264},
journal = {BLOOD ADVANCES},
pages = {301--325},
title = {ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease},
url = {http://dx.doi.org/10.1182/bloodadvances.2020003264},
volume = {5},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Connell,NT
AU - Flood,VH
AU - Brignardello-Petersen,R
AU - Abdul-Kadir,R
AU - Arapshian,A
AU - Couper,S
AU - Grow,JM
AU - Kouides,P
AU - Laffan,M
AU - Lavin,M
AU - Leebeek,FWG
AU - O'Brien,SH
AU - Ozelo,MC
AU - Tosetto,A
AU - Weyand,AC
AU - James,PD
AU - Kalot,MA
AU - Husainat,N
AU - Mustafa,RA
DO - 10.1182/bloodadvances.2020003264
EP - 325
PY - 2021///
SN - 2473-9529
SP - 301
TI - ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease
T2 - BLOOD ADVANCES
UR - http://dx.doi.org/10.1182/bloodadvances.2020003264
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000607932700034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 5
ER -